SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Rudy Saucillo who wrote (1434)9/27/1998 10:55:00 PM
From: Steve Harmon  Respond to of 2742
 
Rudy,

Agreed. With all of the flu news coming out of ICAAC this weekend what a perfect time for the Pasteur Merieux-Cistron flu vaccine adjuvant definitive agreement news release to be made. Pasteur Merieux is after all the leading U.S. flu vaccine producer!

Steve



To: Rudy Saucillo who wrote (1434)9/28/1998 4:18:00 PM
From: Steve Harmon  Read Replies (2) | Respond to of 2742
 
10-K is out. Current Flu vaccine adjuvant study was disappointing.



To: Rudy Saucillo who wrote (1434)9/29/1998 9:55:00 AM
From: Steve Harmon  Read Replies (1) | Respond to of 2742
 
Rudy,

You were right>>>this will be an interesting week. Cistron is trading at lower levels now than before the IMNX $21 million settlement two years ago....AMAZING!


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News